Trial intelligence / Profile preview

Islet transplant in type 1 diabetes

NCT03698396Phase 2Unknown

Start
Aug 2019
Primary completion
Nov 2021
Countries
1
01

Overview

A Phase 2 trial of Allogenic Islet Cell Transplantation in type 1 diabetes mellitus (T1D). Status: unknown.

02

Drugs

Allogenic Islet Cell Transplantation
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT03698396.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03698396.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call